Author

Julia Dao

Lysosomal and Rare Disorders Research and Treatment Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Armaghan Hafez Sanati· 1 shared Benjamin Adewale· 1 shared Jacqueline Fikry· 1 shared Lauren Noll· 1 shared Margarita M. IvanovaiD· 1 shared Neil Kasaci· 1 shared Özlem Göker-AlpaniD· 1 shared Shaista Nazari· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Armaghan Hafez Sanati

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

{-}Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease{-}

Margarita M. Ivanova, Julia Dao, Neil Kasaci, Benjamin Adewale, Shaista Nazari, Lauren Noll, Jacqueline Fikry, Armaghan Hafez Sanati, Özlem Göker-Alpan

This study compares the effects of chaperone (AMB) and substrate reduction (EGT) therapies on GCase activity, autophagy, and mitochondrial function in GD2-3 patient-derived cells.

PLoS ONE · Oct 25, 2021Peer-reviewedMolecular Biology